Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
NVIDIA
NVDA
|
$962M |
| 2 |
Cisco
CSCO
|
$202M |
| 3 |
Amazon
AMZN
|
$165M |
| 4 |
Johnson & Johnson
JNJ
|
$153M |
| 5 |
Pinduoduo
PDD
|
$131M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$468M |
| 2 |
Merck
MRK
|
$306M |
| 3 |
ATVI
Activision Blizzard Inc.
ATVI
|
$305M |
| 4 |
TWNK
Hostess Brands, Inc. Class A Common Stock
TWNK
|
$299M |
| 5 |
TRTN
Triton International Limited
TRTN
|
$282M |
Sector Composition
| 1 | Technology | 18.21% |
| 2 | Financials | 17.12% |
| 3 | Industrials | 13% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Healthcare | 10.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3376
Dolphin Entertainment
DLPN
$14.2M
| $31.1K | ﹤0.01% |
18,184
| – | – |
|
3377
Check-Cap
CHEK
$3.8M
| $31K | ﹤0.01% |
+14,898
| New | +$31K |
|
3378
BlackSky Technology
BKSY
$602M
| $29K | ﹤0.01% |
20,736
| – | – |
|
3379
Intellicheck
IDN
$108M
| $28.9K | ﹤0.01% |
15,213
-4,538
| -23% | -$8.62K |
|
|
LGO
3380
Largo
LGO
$96.2M
| $26.7K | ﹤0.01% |
11,560
| – | – |
|
3381
Lyell Immunopharma
LYEL
$207M
| $26.1K | ﹤0.01% |
13,463
| – | – |
|
3382
Veritone
VERI
$167M
| $23.5K | ﹤0.01% |
12,959
-6,285
| -33% | -$11.4K |
|
3383
TherapeuticsMD
TXMD
$12.7M
| $22.8K | ﹤0.01% |
10,154
| – | – |
|
3384
Beyond Air
XAIR
$11.8M
| $21.9K | ﹤0.01% |
11,182
-3,430
| -23% | -$6.72K |
|
|
OKUR
3385
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
| $21.3K | ﹤0.01% |
13,327
-36,503
| -73% | -$58.4K |
|
3386
Cardiff Oncology
CRDF
$141M
| $21K | ﹤0.01% |
14,206
| – | – |
|
3387
Corvus Pharmaceuticals
CRVS
$441M
| $21K | ﹤0.01% |
11,924
-2,966
| -20% | -$5.22K |
|
3388
Immunoprecise Antibodies
IPA
$88.2M
| $20.9K | ﹤0.01% |
12,213
-3,714
| -23% | -$6.35K |
|
3389
Lulu's Fashion Lounge
LVLU
$10.9M
| $20.7K | ﹤0.01% |
+11,135
| New | +$20.7K |
|
3390
Allbirds
BIRD
$52.1M
| $19.9K | ﹤0.01% |
16,206
| – | – |
|
3391
Aqua Metals
AQMS
$5.36M
| $19.6K | ﹤0.01% |
25,774
| – | – |
|
3392
Orion Energy Systems
OESX
$26.3M
| $19.3K | ﹤0.01% |
22,269
-79,881
| -78% | -$69.2K |
|
3393
Portage Biotech
PRTG
$16.2M
| $19K | ﹤0.01% |
10,565
-3,789
| -26% | -$6.82K |
|
3394
Compass Therapeutics
CMPX
$476M
| $17.3K | ﹤0.01% |
11,117
-44
| -0.4% | -$69 |
|
3395
5E Advanced Materials
FEAM
$75.2M
| $17.2K | ﹤0.01% |
+12,164
| New | +$17.2K |
|
3396
Microbot Medical
MBOT
$190M
| $16.8K | ﹤0.01% |
10,231
-4
| -0% | -$7 |
|
3397
Cartesian Therapeutics
RNAC
$267M
| $16.6K | ﹤0.01% |
24,126
| – | – |
|
3398
Kartoon Studios
TOON
$38.4M
| $16.3K | ﹤0.01% |
11,631
| – | – |
|
3399
Spero Therapeutics
SPRO
$118M
| $14.7K | ﹤0.01% |
10,003
-1,750
| -15% | -$2.57K |
|
3400
Cineverse
CNVS
$80.5M
| $14.7K | ﹤0.01% |
10,876
| – | – |
|